Netta Blondheim Shraga

Netta Blondheim Shraga's work experience includes the following roles and companies:

- VP R&D at Brainstorm Cell Therapeutics since 2022.

- Member at WE@HealthTech since 2021.

- Academic Affairs and Networks Project Leader at Teva Pharmaceuticals from 2020 to 2022.

- Scientific Advisor at ImmunoHiTech LTD from 2018 to 2022.

- Senior Scientist, Study Director at Crown Bioscience, Inc. from 2019 to 2020.

- Senior Scientist at LifeMap Sciences from 2011 to 2014.

- Science Excellence Program Teacher at Kinneret Academic College from 2011 to 2012.

- Pathophysiology Lecturer at Dao College from 2010 to 2011.

- Project Manager, Adult Stem Cells Therapy for ALS at Brainstorm Cell Therapeutics from 2006 to 2009.

Netta Blondheim Shraga completed their education starting from 2000 to 2002 at The Hebrew University of Jerusalem, where they obtained a Bachelor of Arts (BA) in Medical Science. Following this, from 2004 to 2005, they pursued a Master's degree (MSc) in Clinical Biochemistry (neurological lab) at Tel Aviv University. Later, they enrolled at Bar-Ilan University from 2014 to 2020, where they completed their Doctor of Philosophy (Ph.D.) in the field of Immunology-Oncology and Personalized Medicine.